SAR1A
gene geneOn this page
Also known as SAR1Sara
Summary
SAR1A (secretion associated Ras related GTPase 1A, HGNC:10534) is a protein-coding gene on chromosome 10q22.1, encoding Small COPII coat GTPase SAR1A (Q9NR31). Small GTPase that cycles between an active GTP-bound and an inactive GDP-bound state and mainly functions in vesicle-mediated endoplasmic reticulum (ER) to Golgi transport.
Enables G protein activity and amino acid sensor activity. Involved in COPII-coated vesicle budding; cellular response to leucine starvation; and negative regulation of TORC1 signaling. Is active in COPII vesicle coat; endoplasmic reticulum exit site; and lysosomal membrane.
Source: NCBI Gene 56681 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 24 total
- Druggable target: yes
- MANE Select transcript:
NM_020150
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10534 |
| Approved symbol | SAR1A |
| Name | secretion associated Ras related GTPase 1A |
| Location | 10q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SAR1, Sara |
| Ensembl gene | ENSG00000079332 |
| Ensembl biotype | protein_coding |
| OMIM | 607691 |
| Entrez | 56681 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 26 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000373236, ENST00000373238, ENST00000373239, ENST00000373241, ENST00000373242, ENST00000452767, ENST00000477464, ENST00000870136, ENST00000870137, ENST00000870138, ENST00000870139, ENST00000870140, ENST00000870141, ENST00000870142, ENST00000870143, ENST00000870144, ENST00000870145, ENST00000912263, ENST00000912264, ENST00000912265, ENST00000912266, ENST00000912267, ENST00000912268, ENST00000912269, ENST00000948610, ENST00000948611, ENST00000948612
RefSeq mRNA: 2 — MANE Select: NM_020150
NM_001142648, NM_020150
CCDS: CCDS7298
Canonical transcript exons
ENST00000373241 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000501177 | 70153838 | 70153969 |
| ENSE00002444343 | 70161004 | 70161069 |
| ENSE00002482832 | 70157764 | 70157867 |
| ENSE00002506810 | 70161619 | 70161738 |
| ENSE00003633397 | 70161858 | 70161931 |
| ENSE00003707369 | 70147289 | 70152592 |
| ENSE00003845969 | 70170413 | 70170514 |
Expression profiles
Bgee: expression breadth ubiquitous, 295 present calls, max score 98.48.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 114.5830 / max 1839.2630, expressed in 1827 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 109827 | 103.5686 | 1827 |
| 109820 | 8.9573 | 1505 |
| 109826 | 0.9961 | 368 |
| 109821 | 0.4723 | 231 |
| 109824 | 0.3736 | 20 |
| 109825 | 0.0996 | 14 |
| 109823 | 0.0904 | 16 |
| 109822 | 0.0251 | 7 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 98.48 | gold quality |
| tendon | UBERON:0000043 | 98.02 | gold quality |
| pericardium | UBERON:0002407 | 98.01 | gold quality |
| stromal cell of endometrium | CL:0002255 | 97.83 | gold quality |
| periodontal ligament | UBERON:0008266 | 97.81 | gold quality |
| hair follicle | UBERON:0002073 | 97.75 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 97.51 | gold quality |
| synovial joint | UBERON:0002217 | 97.45 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 97.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 97.31 | gold quality |
| mammary duct | UBERON:0001765 | 97.31 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 97.31 | gold quality |
| decidua | UBERON:0002450 | 97.22 | gold quality |
| adrenal tissue | UBERON:0018303 | 97.18 | gold quality |
| tibia | UBERON:0000979 | 97.11 | gold quality |
| visceral pleura | UBERON:0002401 | 97.05 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 97.04 | gold quality |
| endothelial cell | CL:0000115 | 96.93 | gold quality |
| saphenous vein | UBERON:0007318 | 96.93 | gold quality |
| pleura | UBERON:0000977 | 96.92 | gold quality |
| olfactory bulb | UBERON:0002264 | 96.92 | gold quality |
| medial globus pallidus | UBERON:0002477 | 96.91 | gold quality |
| parietal pleura | UBERON:0002400 | 96.90 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 96.90 | gold quality |
| buccal mucosa cell | CL:0002336 | 96.89 | gold quality |
| amniotic fluid | UBERON:0000173 | 96.87 | gold quality |
| endometrium | UBERON:0001295 | 96.84 | gold quality |
| mammary gland | UBERON:0001911 | 96.82 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 96.81 | gold quality |
| urethra | UBERON:0000057 | 96.67 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8142 | yes | 80.09 |
| E-MTAB-6379 | no | 5668.39 |
| E-MTAB-7606 | no | 489.63 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NR1I2
miRNA regulators (miRDB)
168 targeting SAR1A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
Literature-anchored findings (GeneRIF, showing 20)
- The Sec31 fragment stimulates GAP activity of Sec23/24, and a convergence of Sec31 and Sec23 residues at the Sar1 GTPase active site explains how GTP hydrolysis is triggered leading to COPII coat disassembly. (PMID:17981133)
- Sar 1 H79G mutants efficiently blocked the plasma membrane trafficking of the Kir3.1/Kir3.4 complex however they did not block the Gbeta1gamma2/Kir3.1 interaction. (PMID:19135528)
- Kir6.2 contains a di-acidic endoplasmic reticulum exit signal, which promotes endoplasmic reticulum exit via a process that requires Sar1. (PMID:19357197)
- the intracellular trafficking of hCaR from the endoplasmic reticulum is Sar1-dependent via coat protein complex-II vesicles. (PMID:20457124)
- lipid-directed and tether-assisted Sar1 organization controls membrane constriction to regulate ER export. (PMID:20624903)
- Sar1 mutant proteins added to metaphase-arrested Xenopus laevis egg extracts cause dramatic effects on membrane organization. (PMID:22605651)
- the behavior of the human of Sar1A and Sar1B, a key component of the COPII family of vesicle coat proteins, was examined. (PMID:22974979)
- Sedlin bound and promoted efficient cycling of Sar1, a guanosine triphosphatase that can constrict membranes, and thus allowed nascent carriers to grow and incorporate procollagen prefibrils. (PMID:23019651)
- although Sar1A antagonizes the lipoprotein secretion-promoting activity of Sar1B, both isoforms modulate the expression of genes encoding cholesterol biosynthetic enzymes and the synthesis of cholesterol de novo. (PMID:24338480)
- Data indicate that hydroxyurea (HU) induces SAR1 protein expression, which in turn activates gamma-globin expression, predominantly through the Gialpha/JNK/Jun pathway. (PMID:24914133)
- SAR1A gene silencing in hepatocytes mimics the effect of ethanol: dedimerization of giantin, arresting PDIA3 in the endoplasmic reticulum (ER) and large-scale alterations in Golgi architecture. (PMID:26607390)
- Sar1 is a novel regulator of endoplasmic reticulum-mitochondrial contact sites in the metazoans. (PMID:27101143)
- No associations were observed between any of the secretion associated Ras related GTPase 1A (SAR1a) promoter variants and baseline fetal hemoglobin HbF among sickle cell disease (SCD) patients. (PMID:28499394)
- Study shows that the bona fide nonglycoprotein Nox5, a transmembrane superoxide-producing NADPH oxidase, is transported to the cell surface in a manner resistant to co-expression of Sar1 (H79G), a GTP-fixed mutant of the small GTPase Sar1, which blocks COPII vesicle fission from the endoplasmic reticulum. (PMID:29718541)
- The Sar1 and PREB are upregulated following the induction of morphological differentiation, suggesting the potential role of signaling through Sar1a during morphological differentiation. (PMID:30078678)
- Study data suggest that SAR1A and SAR1B are the critical regulators of trafficking of Nav1.5. Moreover, SAR1A and SAR1B interact with MOG1, and are required for MOG1-mediated cell surface expression and function of Nav1.5. (PMID:30251687)
- FABP5 promotes the budding of particles approximately 150 nm in diameter and modulates the kinetics of the SAR1 GTPase cycle. (PMID:30485159)
- Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly. (PMID:32358066)
- SAR1A regulates the RhoA/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis. (PMID:36047971)
- Functional overlap between the mammalian Sar1a and Sar1b paralogs in vivo. (PMID:38687799)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Sar1a | ENSMUSG00000020088 |
| rattus_norvegicus | Ppa1 | ENSRNOG00000000557 |
Paralogs (30): ARF5 (ENSG00000004059), ARFRP1 (ENSG00000101246), TRIM23 (ENSG00000113595), ARL6 (ENSG00000113966), ARL1 (ENSG00000120805), ARL4A (ENSG00000122644), ARL8B (ENSG00000134108), ARF3 (ENSG00000134287), ARL3 (ENSG00000138175), ARL5C (ENSG00000141748), ARF1 (ENSG00000143761), ARL8A (ENSG00000143862), ARL11 (ENSG00000152213), SAR1B (ENSG00000152700), ARL5A (ENSG00000162980), ARF6 (ENSG00000165527), ARL5B (ENSG00000165997), ARF4 (ENSG00000168374), ARL13B (ENSG00000169379), ARL13A (ENSG00000174225), ARL10 (ENSG00000175414), ARL4D (ENSG00000175906), ARL14 (ENSG00000179674), ARL15 (ENSG00000185305), ARL17A (ENSG00000185829), ARL4C (ENSG00000188042), ARL9 (ENSG00000196503), ARL2 (ENSG00000213465), ARL16 (ENSG00000214087), ARL17B (ENSG00000228696)
Protein
Protein identifiers
Small COPII coat GTPase SAR1A — Q9NR31 (reviewed: Q9NR31)
Alternative names: COPII-associated small GTPase, Secretion-associated Ras-related GTPase 1A
All UniProt accessions (5): Q9NR31, H0Y5E8, Q5SQT8, Q5SQT9, X1WI22
UniProt curated annotations — full annotation on UniProt →
Function. Small GTPase that cycles between an active GTP-bound and an inactive GDP-bound state and mainly functions in vesicle-mediated endoplasmic reticulum (ER) to Golgi transport. The active GTP-bound form inserts into the endoplasmic reticulum membrane where it recruits the remainder of the coat protein complex II/COPII. The coat protein complex II assembling and polymerizing on endoplasmic reticulum membrane is responsible for both the sorting of cargos and the deformation and budding of membranes into vesicles destined to the Golgi. The GTPase activity of SAR1 by controlling the timing of COPII budding regulates the size of the formed vesicles and is important for cargo selection depending on their size. Together with SEC16A, forms the organized scaffold defining endoplasmic reticulum exit sites (ERES), some specific domains of the endoplasmic reticulum where COPII vesicles form. In addition to its role in vesicle trafficking, can also function as a leucine sensor regulating TORC1 signaling and more indirectly cellular metabolism, growth and survival. In absence of leucine, interacts with the GATOR2 complex via MIOS and inhibits TORC1 signaling. The binding of leucine abrogates the interaction with GATOR2 and the inhibition of the TORC1 signaling. This function is completely independent of the GTPase activity of SAR1B.
Subunit / interactions. Homodimer; upon association with membrane. Part of the coat protein complex II/COPII, composed of SEC23/24 and SEC13/31 heterodimers, that it helps recruit and assemble on endoplasmic reticulum (ER) membranes at ER exit sites. Interacts with PREB; PREB acts as a guanine nucleotide exchange factor facilitating the activation of SAR1B by loading it with GTP. Interacts with B3GAT1. Interacts with MIOS; the interaction is direct, disrupted by the binding of leucine and mediates the interaction of SAR1A with the GATOR2 complex to negatively regulate the TORC1 signaling upon leucine deprivation.
Subcellular location. Endoplasmic reticulum membrane. Golgi apparatus. Golgi stack membrane. Cytoplasm. Cytosol. Lysosome membrane.
Activity regulation. Small GTPases activation is mediated by guanine exchange factors (GEF), while inactivation through hydrolysis of the bound GTP is stimulated by GTPase activating proteins (GAP). Activated by the guanine nucleotide exchange factor PREB/SEC12 that facilitates the loading of SAR1B with GTP. Inhibited by the alarmone ppGpp.
Similarity. Belongs to the small GTPase superfamily. SAR1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NR31-1 | 1 | yes |
| Q9NR31-2 | 2 |
RefSeq proteins (2): NP_001136120, NP_064535* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005225 | Small_GTP-bd | Domain |
| IPR006687 | Small_GTPase_SAR1 | Family |
| IPR006689 | Small_GTPase_ARF/SAR | Family |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
Pfam: PF00025
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (47 total): binding site 23, helix 9, strand 6, turn 3, chain 1, region of interest 1, short sequence motif 1, modified residue 1, splice variant 1, mutagenesis site 1
Structure
Experimental structures (PDB)
6 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8DZM | X-RAY DIFFRACTION | 1.65 |
| 8DZO | X-RAY DIFFRACTION | 1.8 |
| 8DZT | X-RAY DIFFRACTION | 1.8 |
| 2GAO | X-RAY DIFFRACTION | 2 |
| 8E0H | X-RAY DIFFRACTION | 2 |
| 8DZN | X-RAY DIFFRACTION | 2.11 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NR31-F1 | 85.64 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (23): 38; 39; 39; 40; 40; 75; 134; 134; 135; 135; 137; 137 …
Post-translational modifications (1): 139
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 79 | decreases transport of sting1 from the endoplasmic reticulum to the golgi. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 284 (showing top):
GCACCTT_MIR18A_MIR18B, YAGI_AML_WITH_INV_16_TRANSLOCATION, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_VESICLE_LOCALIZATION, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, BASSO_B_LYMPHOCYTE_NETWORK, GOCC_VACUOLAR_MEMBRANE, GOBP_VESICLE_ORGANIZATION, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_VESICLE_TARGETING, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN
GO Biological Process (12): obsolete regulation of COPII vesicle coating (GO:0003400), intracellular protein transport (GO:0006886), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), vesicle organization (GO:0016050), COPII vesicle coat assembly (GO:0048208), membrane organization (GO:0061024), COPII-coated vesicle cargo loading (GO:0090110), regulation of TORC1 signaling (GO:1903432), negative regulation of TORC1 signaling (GO:1904262), cellular response to leucine starvation (GO:1990253), protein transport (GO:0015031), vesicle-mediated transport (GO:0016192)
GO Molecular Function (7): GTPase activity (GO:0003924), G protein activity (GO:0003925), GTP binding (GO:0005525), amino acid sensor activity (GO:0140785), nucleotide binding (GO:0000166), protein binding (GO:0005515), hydrolase activity (GO:0016787)
GO Cellular Component (11): lysosomal membrane (GO:0005765), endoplasmic reticulum membrane (GO:0005789), cytosol (GO:0005829), COPII vesicle coat (GO:0030127), Golgi cisterna membrane (GO:0032580), endoplasmic reticulum exit site (GO:0070971), cytoplasm (GO:0005737), lysosome (GO:0005764), endoplasmic reticulum (GO:0005783), Golgi apparatus (GO:0005794), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| cellular anatomical structure | 4 |
| intracellular transport | 3 |
| intracellular protein localization | 2 |
| COPII-coated vesicle budding | 2 |
| TORC1 signaling | 2 |
| transport | 2 |
| organelle membrane | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| protein transport | 1 |
| intercellular transport | 1 |
| Golgi vesicle transport | 1 |
| organelle organization | 1 |
| vesicle coat assembly | 1 |
| protein-containing complex assembly | 1 |
| cellular component organization | 1 |
| vesicle cargo loading | 1 |
| regulation of TOR signaling | 1 |
| negative regulation of TOR signaling | 1 |
| regulation of TORC1 signaling | 1 |
| cellular response to amino acid starvation | 1 |
| establishment of protein localization | 1 |
| cellular process | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| GTPase activity | 1 |
| molecular function regulator activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| molecular sensor activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| catalytic activity | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| ER to Golgi transport vesicle membrane | 1 |
| vesicle coat | 1 |
Protein interactions and networks
STRING
1428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SAR1A | PREB | Q9HCU5 | 961 |
| SAR1A | SEC13 | P55735 | 959 |
| SAR1A | SEC31A | O94979 | 929 |
| SAR1A | SEC24B | O95487 | 928 |
| SAR1A | SEC24C | P53992 | 920 |
| SAR1A | SEC16A | O15027 | 908 |
| SAR1A | SEC23A | Q15436 | 903 |
| SAR1A | SEC24A | O95486 | 895 |
| SAR1A | SEC24D | O94855 | 875 |
| SAR1A | SEC23B | Q15437 | 844 |
| SAR1A | GOLPH3 | Q9H4A6 | 843 |
| SAR1A | SEC16B | Q96JE7 | 807 |
| SAR1A | LMAN1 | P49257 | 759 |
| SAR1A | SURF4 | O15260 | 722 |
| SAR1A | SEC22B | O75396 | 676 |
IntAct
288 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SAR1A | SAR1B | psi-mi:“MI:0915”(physical association) | 0.590 |
| VKORC1 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC38A7 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GIMAP1 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLPP4 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC30A8 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHFPL5 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| MOSPD3 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAMP3 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP10 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLDND2 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| MIP | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCL2L2 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAR1A | SLC38A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM3C | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GYPA | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAR1A | ORMDL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (391): SAR1A (Affinity Capture-RNA), SAR1A (Affinity Capture-RNA), SAR1A (Affinity Capture-MS), SAR1A (Affinity Capture-MS), SAR1A (Affinity Capture-RNA), HMBS (Co-fractionation), SAR1A (Co-fractionation), SAR1A (Co-fractionation), SAR1A (Co-fractionation), SAR1A (Co-fractionation), SEC31A (Co-fractionation), SAR1A (Proximity Label-MS), SAR1B (Affinity Capture-MS), SAR1A (Affinity Capture-MS), SAR1A (Affinity Capture-MS)
ESM2 similar proteins: A1CRG9, A1D4D1, A3LTA2, A5DR82, A5E5G3, O04266, O04267, O04834, P0C583, P0C950, P0C951, P0CR30, P0CR31, P0CT16, P0CT17, P20606, P36536, P52884, P78976, Q01474, Q01475, Q02804, Q0CUN7, Q0UKC0, Q13795, Q23445, Q2HA55, Q3T0D7, Q3T0T7, Q4P0I7, Q4WJS7, Q52NJ3, Q559R0, Q59S78, Q5BGB9, Q5HZY2, Q5PYH3, Q5R548, Q5R579, Q6BVA7
Diamond homologs: A1CRG9, A1D4D1, A3LTA2, A5DR82, A5E5G3, A8ISN6, O04266, O04267, O04834, O45379, O48649, O48920, P0C583, P0C950, P0C951, P0CM16, P0CM17, P0CR30, P0CR31, P0CT16, P0CT17, P0DH91, P11076, P18085, P19146, P20606, P22274, P34727, P36397, P36536, P36579, P38116, P40940, P40945, P40994, P49702, P51643, P51821, P51823, P51824
SIGNOR signaling
8 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SIRT7 | “up-regulates activity” | SAR1A | deacetylation |
| SAR1A | “up-regulates quantity” | SEC23B | binding |
| SAR1A | “up-regulates quantity” | SEC23A | binding |
| SAR1A | “up-regulates quantity” | SEC24B | binding |
| SAR1A | “up-regulates quantity” | SEC24D | binding |
| SAR1A | “up-regulates quantity” | SEC24C | binding |
| SAR1A | “up-regulates quantity” | SEC24A | binding |
| SAR1A | “up-regulates quantity” | “COPII vesicle” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1412 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:70152588:TTCCC:T | acceptor_gain | 1.0000 |
| 10:70152590:CCC:C | acceptor_gain | 1.0000 |
| 10:70152591:CCC:C | acceptor_gain | 1.0000 |
| 10:70153832:TCTTA:T | donor_loss | 1.0000 |
| 10:70153833:CTTAC:C | donor_loss | 1.0000 |
| 10:70153834:TTACC:T | donor_loss | 1.0000 |
| 10:70153835:TACCT:T | donor_loss | 1.0000 |
| 10:70153836:A:AC | donor_gain | 1.0000 |
| 10:70153837:C:CG | donor_gain | 1.0000 |
| 10:70153837:CCTTT:C | donor_gain | 1.0000 |
| 10:70153841:T:A | donor_gain | 1.0000 |
| 10:70153965:AAAGC:A | acceptor_gain | 1.0000 |
| 10:70153966:AAGC:A | acceptor_gain | 1.0000 |
| 10:70153967:AGC:A | acceptor_gain | 1.0000 |
| 10:70153967:AGCCT:A | acceptor_loss | 1.0000 |
| 10:70153968:GC:G | acceptor_gain | 1.0000 |
| 10:70153968:GCC:G | acceptor_loss | 1.0000 |
| 10:70153969:CC:C | acceptor_gain | 1.0000 |
| 10:70153969:CCT:C | acceptor_loss | 1.0000 |
| 10:70153970:C:A | acceptor_loss | 1.0000 |
| 10:70153970:C:CC | acceptor_gain | 1.0000 |
| 10:70153970:C:T | acceptor_gain | 1.0000 |
| 10:70153971:T:A | acceptor_loss | 1.0000 |
| 10:70153976:A:AC | acceptor_gain | 1.0000 |
| 10:70153976:A:C | acceptor_gain | 1.0000 |
| 10:70153977:T:C | acceptor_gain | 1.0000 |
| 10:70153977:T:TC | acceptor_gain | 1.0000 |
| 10:70157762:A:AC | donor_gain | 1.0000 |
| 10:70157763:C:CC | donor_gain | 1.0000 |
| 10:70157774:A:C | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000293945 (10:70158406 G>A), RS1000438846 (10:70149185 C>A), RS1000469895 (10:70149397 G>A), RS1000602365 (10:70160572 A>G), RS1000647144 (10:70164976 G>A,T), RS1000658992 (10:70157959 G>A,T), RS1000678383 (10:70165133 C>A,T), RS1001036723 (10:70160310 A>C), RS1001182398 (10:70167608 A>G), RS1001265575 (10:70155240 T>A,C), RS1001695515 (10:70154926 G>T), RS1001769412 (10:70161933 T>C), RS1001910849 (10:70156866 T>C), RS1002101705 (10:70148001 C>T), RS1002132808 (10:70159881 T>G)
Disease associations
OMIM: gene MIM:607691 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4295960 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
41 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases expression, decreases expression, increases abundance | 4 |
| bisphenol A | increases expression, affects cotreatment | 3 |
| Tobacco Smoke Pollution | increases expression | 2 |
| bisphenol F | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| nickel chloride | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ochratoxin A | affects binding | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| ochratoxin B | affects binding | 1 |
| dimethylarsinous acid | increases expression | 1 |
| nutlin 3 | increases secretion, affects cotreatment | 1 |
| bisphenol B | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| bisphenol S | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases secretion | 1 |
| Dexamethasone | increases expression, affects cotreatment | 1 |
| Indomethacin | increases expression, affects cotreatment | 1 |
| Isoniazid | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Nickel | increases expression | 1 |
| Phthalic Acids | increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4118667 | Binding | Binding affinity to SAR1A in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay | Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — Bioorg Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.